About Recombia Biosciences
Recombia Biosciences is a company based in Brisbane (United States) founded in 2019 by Bob St.Onge, Justin D Smith, and Lars Steinmetz was acquired by Lesaffre in September 2022.. Recombia Biosciences offers products and services including Yeast for Bread Making, Proteins and Enzymes, Biobased Chemicals, Biofuels, and Extracts and Feed. Recombia Biosciences operates in a competitive market with competitors including Beam Therapeutics, eGenesis, Korro Bio, Novogene Corporation and Metagenomi, among others.
- Headquarter Brisbane, United States
- Founders Bob St.Onge, Justin D Smith, Lars Steinmetz
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Recombia Biosciences
Recombia Biosciences offers a comprehensive portfolio of products and services, including Yeast for Bread Making, Proteins and Enzymes, Biobased Chemicals, Biofuels, and Extracts and Feed. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides yeast for industrial bread production through metabolic engineering.
Develops proteins and enzymes for various industrial applications.
Creates chemicals from microorganisms for eco-friendly uses.
Produces biofuels via fermentation for renewable energy needs.
Offers extracts and feed solutions derived from engineered microorganisms.
Supports winemaking and brewing with optimized microbial solutions.
Unlock access to complete
Unlock access to complete
Funding Insights of Recombia Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Recombia Biosciences
Recombia Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lesaffre. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of yeast and its related products
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Recombia Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Recombia Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Recombia Biosciences Comparisons
Competitors of Recombia Biosciences
Recombia Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beam Therapeutics, eGenesis, Korro Bio, Novogene Corporation and Metagenomi, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| domain | founded_year | HQ Location |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Genomic services and solutions with NGS expertise are provided.
|
|
| domain | founded_year | HQ Location |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| domain | founded_year | HQ Location |
Genetic therapies for diseases are developed using prime editing technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Recombia Biosciences
Frequently Asked Questions about Recombia Biosciences
When was Recombia Biosciences founded?
Recombia Biosciences was founded in 2019.
Where is Recombia Biosciences located?
Recombia Biosciences is headquartered in Brisbane, United States. It is registered at Brisbane, California, United States.
Who is the current CEO of Recombia Biosciences?
Justin D Smith is the current CEO of Recombia Biosciences. They have also founded this company.
What does Recombia Biosciences do?
Recombia Biosciences was founded in 2019 in Brisbane, United States, within the biotechnology sector. A proprietary platform for genome editing and genetic engineering is offered, focused on sustainable product development. Operations involve the use of Saccharomyces cerevisiae yeast, where gene sequences are replaced to enhance industrial fermentation traits. This approach is designed to lower manufacturing costs and simplify downstream processing for various applications.
Who are the top competitors of Recombia Biosciences?
Recombia Biosciences's top competitors include eGenesis, Tessera Therapeutics and Novogene Corporation.
What products or services does Recombia Biosciences offer?
Recombia Biosciences offers Yeast for Bread Making, Proteins and Enzymes, Biobased Chemicals, Biofuels, and 2 more products and services.
Who are Recombia Biosciences's investors?
Recombia Biosciences has 1 investor. Key investors include Lesaffre.